DOJ and Danco Laboratories petition Supreme Court over mifepristone restrictions

The De­part­ment of Jus­tice and mifepri­s­tone man­u­fac­tur­er Dan­co Lab­o­ra­to­ries have pe­ti­tioned the Supreme Court to re­view a low­er court’s de­ci­sion that would lim­it use of the abor­tion pill.

The pe­ti­tions, filed sep­a­rate­ly on Fri­day, take is­sue with a Fifth Cir­cuit court de­ci­sion that would re­strict mifepri­s­tone’s use to con­di­tions that ex­ist­ed be­fore the FDA loos­ened some of its reg­u­la­tions in 2016 and al­lowed the drug to be dis­trib­uted by mail in 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.